II Robert C. Goeltz
CIK 1653881 · Chief Financial Officer · last filed 2026-05-12
II Robert C. Goeltz is a Chief Financial Officer who has filed 38 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing shows the insider sold $199.0K of RCUS on May 12, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.07M
3
38
-$1.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCUS | Chief Financial Officer | 84,161 | $23.80 | $2.00M | -$1.04M | 21 | 2026-05-12 |
| Unity Biotechnology, Inc. (UBX) Delisted | Chief Financial Officer | 161,027 | $0.20 | $32.2K | $0 | 8 | 2020-06-24 |
| CTMX | Chief Financial Officer | 22,769 | $3.01 | $68.5K | -$426.3K | 9 | 2017-05-16 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-12 | RCUS | Sell (S) | −7,763 | -$199.0K | EDGAR |
| 2026-01-26 | RCUS | Grant (A) | +24,000 | $0 | EDGAR |
| 2026-01-02 | RCUS | Sell (S) | −6,552 | -$153.2K | EDGAR |
| 2025-12-18 | RCUS | Sell (S) | −12,662 | -$278.7K | EDGAR |
| 2025-11-26 | RCUS | Sell (S) | −5,000 | -$125.0K | EDGAR |
| 2025-10-29 | RCUS | Sell (S) | −5,000 | -$100.0K | EDGAR |
| 2025-01-27 | RCUS | Grant (A) | +37,000 | $0 | EDGAR |
| 2025-01-03 | RCUS | Sell (S) | −3,594 | -$53.9K | EDGAR |
| 2024-12-17 | RCUS | Tax (F) | −10,099 | -$162.4K | EDGAR |
| 2024-02-23 | RCUS | Grant (A) | +22,000 | $0 | EDGAR |